Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells

INTRODUCTION: Several cytotoxic anticancer drugs inhibit DNA replication and/or mitosis, while EGFR tyrosine kinase inhibitors inactivate EGFR signalling in cancer cell. Both types of anticancer drugs improve the overall survival of the patients with non-small-cell lung cancer (NSCLC), although tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Okita, Riki, Wolf, Diana, Yasuda, Koichiro, Maeda, Ai, Yukawa, Takuro, Saisho, Shinsuke, Shimizu, Katsuhiko, Yamaguchi, Yoshiyuki, Oka, Mikio, Nakayama, Eiichi, Lundqvist, Andreas, Kiessling, Rolf, Seliger, Barbara, Nakata, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595469/
https://www.ncbi.nlm.nih.gov/pubmed/26439264
http://dx.doi.org/10.1371/journal.pone.0139809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595469/
https://www.ncbi.nlm.nih.gov/pubmed/26439264
http://dx.doi.org/10.1371/journal.pone.0139809

Ejemplares similares